Stock listing
Lang & Schwarz:A2QA48 Actinium Pharmaceuticals, Inc. (Delaware) Aktie
German listing (Lang & Schwarz) of Actinium Pharmaceuticals, Inc. (Delaware) · home listing NYSE American:ATNM
Follow Actinium Pharmaceuticals, Inc. (Delaware) into a list and get an email when it puts out news.
Home listing price · AMEX:ATNM
$1.32 USD +0.19 (+16.8%)
Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, AMEX:ATNM
- Day range
- $1.13 – $1.40 USDOct 19, 2026
- Volume
- 656,796 sharesOct 19, 2026
- Market cap
- $41.50M USDAt the close on Oct 19, 2026 · price × 31.44M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:ATNM · Home | $1.32 USD | +0.19 (+16.8%) | 656,796 | $1.14 | $1.399 | $1.13 | $1.13 | Close on Oct 19, 2026 |
| Frankfurt:7AY1 | €1.004 EUR | +0.157 (+18.5%) | 302 | €0.987 | €1.004 | €0.987 | €0.847 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · AMEX:ATNM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.32 | +0.19 | +16.8% | $1.14 | $1.399 | $1.13 | 656,796 | |
| $1.13 | +0.07 | +6.6% | $1.09 | $1.15 | $1.05 | 174,390 | |
| $1.06 | +0.085 | +8.8% | $0.95 | $1.068 | $0.95 | 143,235 | |
| $0.975 | -0.025 | -2.5% | $0.99 | $1.023 | $0.953 | 84,633 | |
| $1.00 | -0.061 | -5.7% | $1.07 | $1.07 | $0.996 | 89,242 | |
| $1.06 | -0.04 | -3.6% | $1.09 | $1.09 | $1.029 | 97,600 | |
| $1.10 | +0.02 | +1.9% | $1.09 | $1.12 | $1.07 | 105,800 | |
| $1.08 | +0.01 | +0.9% | $1.09 | $1.10 | $1.06 | 104,900 | |
| $1.07 | -0.04 | -3.6% | $1.08 | $1.12 | $1.05 | 100,100 | |
| $1.11 | -0.09 | -7.5% | $1.20 | $1.22 | $1.02 | 439,600 | |
| $1.20 | +0.03 | +2.6% | $1.16 | $1.24 | $1.16 | 115,000 | |
| $1.17 | +0.02 | +1.7% | $1.15 | $1.19 | $1.12 | 81,800 | |
| $1.15 | +0.03 | +2.7% | $1.11 | $1.15 | $1.11 | 90,800 | |
| $1.12 | -0.02 | -1.8% | $1.14 | $1.20 | $1.10 | 95,100 | |
| $1.14 | -0.04 | -3.4% | $1.17 | $1.17 | $1.14 | 62,022 | |
| $1.18 | -0.02 | -1.7% | $1.18 | $1.20 | $1.17 | 75,373 | |
| $1.20 | +0.01 | +0.8% | $1.19 | $1.205 | $1.18 | 28,400 | |
| $1.19 | +0.01 | +0.8% | $1.19 | $1.25 | $1.18 | 84,800 | |
| $1.18 | +0.01 | +0.9% | $1.17 | $1.21 | $1.16 | 130,400 | |
| $1.17 | -0.03 | -2.5% | $1.18 | $1.22 | $1.17 | 54,500 | |
| $1.20 | -0.02 | -1.6% | $1.24 | $1.24 | $1.166 | 99,400 | |
| $1.22 | +0.03 | +2.5% | $1.18 | $1.23 | $1.18 | 146,200 | |
| $1.19 | -0.05 | -4.0% | $1.26 | $1.26 | $1.18 | 56,700 | |
| $1.24 | -0.01 | -0.8% | $1.26 | $1.275 | $1.24 | 59,800 | |
| $1.25 | -0.03 | -2.3% | $1.28 | $1.32 | $1.25 | 96,100 | |
| $1.28 | -0.12 | -8.6% | $1.41 | $1.418 | $1.25 | 301,500 | |
| $1.40 | +0.09 | +6.9% | $1.31 | $1.42 | $1.285 | 238,200 | |
| $1.31 | +0.08 | +6.5% | $1.25 | $1.34 | $1.23 | 226,800 | |
| $1.23 | 0.00 | 0.0% | $1.24 | $1.305 | $1.22 | 366,600 | |
| $1.23 | +0.20 | +19.4% | $1.06 | $1.25 | $1.06 | 574,100 | |
| $1.03 | -0.02 | -1.9% | $1.05 | $1.055 | $1.02 | 54,000 | |
| $1.05 | +0.05 | +5.0% | $1.02 | $1.06 | $1.01 | 72,000 | |
| $1.00 | +0.004 | +0.4% | $1.00 | $1.04 | $1.00 | 74,900 | |
| $0.996 | -0.024 | -2.4% | $1.01 | $1.022 | $0.996 | 30,100 | |
| $1.02 | +0.01 | +1.0% | $1.03 | $1.03 | $1.01 | 34,800 | |
| $1.01 | +0.01 | +1.0% | $1.00 | $1.028 | $0.97 | 111,600 | |
| $1.00 | -0.01 | -1.0% | $1.01 | $1.05 | $1.00 | 92,900 | |
| $1.01 | -0.07 | -6.5% | $1.08 | $1.08 | $1.01 | 145,100 | |
| $1.08 | +0.03 | +2.9% | $1.07 | $1.10 | $1.05 | 159,003 | |
| $1.05 | -0.05 | -4.5% | $1.10 | $1.10 | $1.04 | 64,454 | |
| $1.10 | -0.02 | -1.8% | $1.13 | $1.14 | $1.10 | 143,800 | |
| $1.12 | -0.01 | -0.9% | $1.13 | $1.14 | $1.07 | 121,400 | |
| $1.13 | +0.05 | +4.6% | $1.09 | $1.15 | $1.05 | 183,400 | |
| $1.08 | +0.03 | +2.9% | $1.05 | $1.115 | $1.03 | 211,200 | |
| $1.05 | +0.01 | +1.0% | $1.11 | $1.13 | $1.05 | 344,600 | |
| $1.04 | +0.076 | +7.9% | $0.95 | $1.09 | $0.935 | 490,500 | |
| $0.964 | +0.143 | +17.4% | $0.849 | $0.98 | $0.845 | 284,500 | |
| $0.821 | +0.028 | +3.5% | $0.80 | $0.829 | $0.79 | 240,600 | |
| $0.793 | +0.023 | +3.0% | $0.78 | $0.824 | $0.77 | 168,800 | |
| $0.77 | -0.027 | -3.4% | $0.80 | $0.808 | $0.76 | 177,200 | |
| $0.797 | +0.01 | +1.3% | $0.79 | $0.80 | $0.772 | 133,100 | |
| $0.787 | +0.038 | +5.1% | $0.75 | $0.789 | $0.747 | 98,900 | |
| $0.749 | -0.061 | -7.5% | $0.80 | $0.805 | $0.735 | 349,500 | |
| $0.81 | -0.002 | -0.2% | $0.811 | $0.83 | $0.81 | 92,100 | |
| $0.812 | -0.025 | -3.0% | $0.837 | $0.862 | $0.81 | 199,900 | |
| $0.837 | 0.00 | 0.0% | $0.837 | $0.85 | $0.837 | 35,400 | |
| $0.837 | 0.00 | 0.0% | $0.837 | $0.85 | $0.837 | 26,300 | |
| $0.837 | -0.03 | -3.5% | $0.85 | $0.882 | $0.834 | 80,800 | |
| $0.867 | +0.013 | +1.5% | $0.86 | $0.867 | $0.845 | 72,400 | |
| $0.854 | -0.006 | -0.7% | $0.88 | $0.88 | $0.807 | 123,700 | |
| $0.86 | -0.031 | -3.5% | $0.89 | $0.903 | $0.86 | 113,200 | |
| $0.891 | -0.009 | -1.0% | $0.91 | $0.91 | $0.886 | 130,300 | |
| $0.90 | 0.00 | 0.0% | $0.897 | $0.919 | $0.88 | 67,900 | |
| $0.90 | +0.017 | +1.9% | $0.89 | $0.92 | $0.89 | 50,585 | |
| $0.883 | -0.039 | -4.2% | $0.90 | $0.904 | $0.882 | 89,939 |
- Ticker
- Lang & Schwarz:A2QA48
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Oct 20, 2026
Actinium Pharmaceuticals Unveils ATNM‑400 Data at EANM 2026 with a First‑In‑Human HER3‑Targeted Radiotherapy Approach Beyond PSMA in Prostate Cancer
Latest deck · October 2026
Actinium Pharmaceuticals — Investor Presentation (October 2026)
Investor deck · 26 slides
Latest news
Actinium Pharmaceuticals to Showcase ATNM-400's First-in-Human Clinical Data in Prostate Cancer and Preclinical Results in Lung Cancer Supporting Pan-Tumor Potential Today at EANM 2026
Oct 19, 2026
Closed $1.32 (+16.8%) on Oct 19, 2026
Actinium Pharmaceuticals Announces Inducement Grants to New Employees
Oct 16, 2026
Closed $1.32 (+16.8%) on Oct 19, 2026
Actinium Pharmaceuticals Appoints Radiopharmaceutical Industry Veteran Sean Maenpaa as Senior Vice President, Business Development
Oct 16, 2026
Closed $1.13 (+6.6%) on Oct 16, 2026
Actinium Pharmaceuticals Strengthens Leadership Team with Appointment of Matt David, M.D. as Chief Financial Officer
Oct 15, 2026
Closed $1.06 (+8.8%) on Oct 15, 2026
Decks
Actinium Pharmaceuticals — Investor Presentation (October 2026)
Investor deck · 26 slides · October 2026
Actinium Pharmaceuticals — 4th Annual Targeted Radiotherapeutics Summit 2025
Conference · 24 slides · Jul 30, 2025
Actinium Pharmaceuticals — Technical Presentation (March 2025)
Technical · 43 slides · Mar 25, 2025
Actinium Pharmaceuticals — Technical Presentation (May 2024)
Technical · 35 slides · May 20, 2024
Actinium Pharmaceuticals, Inc. (Delaware) on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 30 in all · newest Oct 20, 2026 · oldest 2025
- Decks
- 19 decks · latest October 2026
Where Actinium Pharmaceuticals, Inc. (Delaware) is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:ATNM · Home listing | NYSE American | United States | USD |
| Lang & Schwarz:A2QA48 · This page | Lang & Schwarz | Germany | EUR |
| gettex:7AY1 | gettex | Germany | EUR |
| LS Exchange:A2QA48 | LS Exchange | Germany | EUR |
| Tradegate:7AY1 | Tradegate | Germany | EUR |
| BOATS:ATNM | BOATS | United States | USD |
| Stuttgart:7AY1 | Stuttgart | Germany | EUR |
| Dusseldorf:7AY1 | Dusseldorf | Germany | EUR |
| Frankfurt:7AY1 | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about Actinium Pharmaceuticals, Inc. (Delaware).